OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding HIV Latency: The Road to an HIV Cure
Matthew S. Dahabieh, Emilie Battivelli, Eric Verdin
Annual Review of Medicine (2015) Vol. 66, Iss. 1, pp. 407-421
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

Targeting the Latent Reservoir for HIV-1
Srona Sengupta, Robert F. Siliciano
Immunity (2018) Vol. 48, Iss. 5, pp. 872-895
Open Access | Times Cited: 314

HIV
Jade Ghosn, Babafemi Taiwo, Soraya Seedat, et al.
The Lancet (2018) Vol. 392, Iss. 10148, pp. 685-697
Closed Access | Times Cited: 264

Latency reversal and viral clearance to cure HIV-1
David M. Margolis, J. Víctor García, Daria J. Hazuda, et al.
Science (2016) Vol. 353, Iss. 6297
Open Access | Times Cited: 221

T‐Cell‐Mimicking Nanoparticles Can Neutralize HIV Infectivity
Xiaoli Wei, Gang Zhang, Danni Ran, et al.
Advanced Materials (2018) Vol. 30, Iss. 45
Open Access | Times Cited: 175

Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells
Emilie Battivelli, Matthew S. Dahabieh, Mohamed Abdel‐Mohsen, et al.
eLife (2018) Vol. 7
Open Access | Times Cited: 166

Biomimetic cell membrane‐coated poly(lactic‐ co ‐glycolic acid) nanoparticles for biomedical applications
Nasrullah Jan, Asadullah Madni, Safiullah Khan, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 2
Open Access | Times Cited: 81

Position effects influence HIV latency reversal
Heng‐Chang Chen, Javier P. Martínez, Eduard Zorita, et al.
Nature Structural & Molecular Biology (2016) Vol. 24, Iss. 1, pp. 47-54
Open Access | Times Cited: 158

Shocking HIV out of hiding
Thomas A. Rasmussen, Sharon R. Lewin
Current Opinion in HIV and AIDS (2016) Vol. 11, Iss. 4, pp. 394-401
Closed Access | Times Cited: 140

The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence
Alexandra J. Murray, Kyungyoon J. Kwon, Donna L. Färber, et al.
The Journal of Immunology (2016) Vol. 197, Iss. 2, pp. 407-417
Open Access | Times Cited: 137

Nuclear landscape of HIV-1 infection and integration
Marina Lušić, Robert F. Siliciano
Nature Reviews Microbiology (2016) Vol. 15, Iss. 2, pp. 69-82
Closed Access | Times Cited: 129

Transcription Factor NF-κB: An Update on Intervention Strategies
Arvind Panday, María Eugenia Inda, Prathyusha Bagam, et al.
Archivum Immunologiae et Therapiae Experimentalis (2016) Vol. 64, Iss. 6, pp. 463-483
Closed Access | Times Cited: 99

Spatially clustered loci with multiple enhancers are frequent targets of HIV-1 integration
Bojana Lucic, Heng‐Chang Chen, Maja Kuzman, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 98

LEDGIN-mediated Inhibition of Integrase–LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV
Lenard Vranckx, Jonas Demeulemeester, Suha Saleh, et al.
EBioMedicine (2016) Vol. 8, pp. 248-264
Open Access | Times Cited: 97

Block-And-Lock: New Horizons for a Cure for HIV-1
Inês Moranguinho, Susana T. Valente
Viruses (2020) Vol. 12, Iss. 12, pp. 1443-1443
Open Access | Times Cited: 73

Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV
Qingli Niu, Zhiqing Liu, Edrous Alamer, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 8, pp. 3361-3373
Open Access | Times Cited: 68

HIV therapeutic vaccines: moving towards a functional cure
Geetha Mylvaganam, Guido Silvestri, Rama Rao Amara
Current Opinion in Immunology (2015) Vol. 35, pp. 1-8
Open Access | Times Cited: 67

Myeloid Cell Interaction with HIV: A Complex Relationship
Vasco Rodrigues, Nicolas Ruffin, Mabel Jouve, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 66

Transcription: Insights From the HIV-1 Promoter
Enrico Ne, Robert‐Jan Palstra, Tokameh Mahmoudi
International review of cell and molecular biology (2017), pp. 191-243
Closed Access | Times Cited: 65

The BET inhibitor OTX015 reactivates latent HIV-1 through P-TEFb
Panpan Lu, Xiying Qu, Yinzhong Shen, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 62

Autosis
Jihoon Nah, Daniela Zablocki, Junichi Sadoshima
JACC Basic to Translational Science (2020) Vol. 5, Iss. 8, pp. 857-869
Open Access | Times Cited: 56

Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies
Tram M. Ta, Sajjaf Malik, Elizabeth M. Anderson, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 35

The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like
Gilles Darcis, Ben Berkhout, Alexander Pasternak
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 53

Pseudouridylation of 7 SK sn RNA promotes 7 SK sn RNP formation to suppress HIV ‐1 transcription and escape from latency
Yang Zhao, John Karijolich, Britt A. Glaunsinger, et al.
EMBO Reports (2016) Vol. 17, Iss. 10, pp. 1441-1451
Open Access | Times Cited: 49

Small Molecule Targeting of Specific BAF (mSWI/SNF) Complexes for HIV Latency Reversal
Christine Marian, Mateusz Stoszko, Lili Wang, et al.
Cell chemical biology (2018) Vol. 25, Iss. 12, pp. 1443-1455.e14
Open Access | Times Cited: 48

Page 1 - Next Page

Scroll to top